Formulation and optimization of nanotransfersomes using experimental design technique for accentuated transdermal delivery of valsartan

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 8, Issue 2, 2012, Pages 237-249

  Ahad, Abdul ^a   Aqil, Mohammed ^a   Kohli, Kanchan ^a   Sultana, Yasmin ^a   Mujeeb, Mohammed ^a   Ali, Asgar ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

Box Behnken design; Elastic liposomes; Hypertension; Transfersomes; Valsartan

Indexed keywords

ANTIHYPERTENSIVE ACTIVITY; BOX-BEHNKEN DESIGN; CONFOCAL LASER SCANNING MICROSCOPY; ENHANCEMENT RATIOS; ENTRAPMENT EFFICIENCY; EVAPORATION METHOD; EXPERIMENTAL DESIGN TECHNIQUES; HYPERTENSION; IN-VIVO; MEASURE OF PERFORMANCE; SKIN PERMEATION; TRANSDERMAL; TRANSDERMAL DELIVERY; TRANSDERMAL FLUX; TRANSFERSOMES; VALSARTAN; WISTAR RAT;

CONFOCAL MICROSCOPY; OPTIMIZATION; PHOSPHOLIPIDS;

LIPOSOMES;

DRUG CARRIER; LIPOSOME; NANOTRANSFERSOME; PLACEBO; UNCLASSIFIED DRUG; VALSARTAN;

ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CONFOCAL LASER MICROSCOPY; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG SYNTHESIS; ENTRAPMENT EFFICIENCY; EVAPORATION; HYPERTENSION; NONHUMAN; PARAMETERS; PARTICLE SIZE; SKIN PENETRATION; SKIN PERMEABILITY;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTIHYPERTENSIVE AGENTS; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; HUMANS; HYPERTENSION; LIPOSOMES; NANOSPHERES; PARTICLE SIZE; RATS; RATS, WISTAR; TETRAZOLES; VALINE;

RATTUS NORVEGICUS;

EID: 84855854929     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2011.06.004     Document Type: Article

References (49)

1. Aqil M., Ahad A., Sultana Y., Ali A. Status of terpenes as skin penetration enhancers. Drug Discov Today 2007, 12:1601-1607.
2. Ahad A., Aqil M., Kohli K., Chaudhary H., Sultana Y., Mujeeb M., et al. Chemical penetration enhancers: a patent review. Expert Opin Ther Patents 2009, 19:969-988.
3. Honeywell-Nguyen P.L., Bouwstra J.A. Vesicles as a tool for transdermal and dermal delivery. Drug Discov Today 2005, 2:67-74.
4. Manosroi A., Jantrawut P., Manosroi J. Anti-inflammatory activity of gel containing novel elastic niosomes entrapped with Diclofenac diethylammonium. Int J Pharm 2008, 360:156-163.
5. Verma D.D., Verma S., Blume G., Fahr A. Liposomes increase skin penetration of entrapped and non-entrapped hydrophilic substances into human skin: a skin penetration and confocal laser scanning microscopy study. Eur J Pharm Biopharm 2003, 55:271-277.
6. Elsayed M.M.A., Abdallah O.Y., Naggar V.F., Khalafallah N.M. Lipid vesicles for skin delivery of drugs: reviewing three decades of research. Int J Pharm 2007, 332:1-16.
7. Cevc G., Blume G. New, highly efficient formulation of diclofenac for the topical, transdermal administration in ultradeformable drug carriers, Transfersomes. Biochim Biophys Acta 2001, 1514:191-205.
8. Cevc G., Blume G. Biological activity and characteristics of triamcinolone-acetonide formulated with the self-regulating drug carriers, Transfersomes. Biochim Biophys Acta 2003, 1614:156-164.
9. Cevc G., Blume G. Hydrocortisone and dexamethasone in very deformable drug carriers have increased biological potency, prolonged effect, and reduced therapeutic dosage. Biochim Biophys Acta 2004, 1663:61-73.
10. Lee E.H., Kim A., Oh Y., Kim C. Effect of edge activators on the formation and transfection efficiency of ultradeformable liposomes. Biomaterials 2005, 26:205-210.
11. Cevc G., Blume G. Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Biochim Biophys Acta 1992, 1104:226-232.
12. Cevc G., Schatzlein A., Richardsen H. Ultra deformable lipid vesicles can penetrate the skin and other semi-permeable barriers unfragmented. Evidence from double label CLSM experiments and direct size measurements. Biochim Biophys Acta 2002, 1564:21-30.
13. Jain S., Jain P., Umamaheshwari R.B., Jain N.K. Transfersomes-a novel vesicular carrier for enhanced transdermal delivery: development, characterization, and performance evaluation. Drug Dev Ind Pharm 2003, 29:1013-1026.
14. Ahad A., Aqil M., Kohli K., Sultana Y., Mujeeb M. Role of novel terpenes in transcutaneous permeation of valsartan: effectiveness and mechanism of action. Drug Dev Ind Pharm 2011, 37:583-596.
15. Rizwan M.D., Aqil M., Ahad A., Sultana Y., Ali M. Transdermal delivery of valsartan: I. Effect of various terpenes. Drug Dev Ind Pharm. 2008, 34:618-626.
16. Nishida N., Taniyama K., Sawabe T., Manome Y. Development and evaluation of a monolithic drug-in-adhesive patch for valsartan. Int J Pharm 2010, 402:103-109.
17. Mishra D., Garg M., Dubey V., Jain S., Jain N.K. Elastic liposomes mediated transdermal delivery of an anti-hypertensive agent: propranolol hydrochloride. J Pharm Sci 2007, 96:145-155.
18. Khajeh M. Application of Box-Behnken design in the optimization of a magnetic nanoparticle procedure for zinc determination in analytical samples by inductively coupled plasma optical emission spectrometry. J Hazard Mater 2009, 172:385-389.
19. Guo J., Ping Q., Sun G., Jiao C. Lecithin vesicular carriers for transdermal delivery of cyclosporine. Int J Pharm 2000, 194:201-207.
20. El Maghraby G.M.M., Williams A.C., Barry B.W. Skin delivery from ultradeformable liposomes: refinement of surfactant concentration. J Pharm Pharmacol 1999, 51:1123-1134.
21. Tatar S., Sasglik S. Comparison of UV- and second derivative spectrophotometric and HPLC methods for the determination of valsartan in pharmaceutical formulation. J Pharm Biomed Anal 2002, 30:371-375.
22. Mura S., Manconi M., Sinico C., Valenti D., Fadda A.M. Penetration enhancer-containing vesicles (PEVs) as carriers for cutaneous delivery of minoxidil. Int J Pharm 2009, 380:72-79.
23. Ahad A., Aqil M., Kohli K., Sultana Y., Mujeeb M. Interactions between novel terpenes and main components of rat and human skin: mechanistic view for transdermal delivery of propranolol hydrochloride. Curr Drug Deliv 2011, 8:213-224.
24. Narishetty S.T.K., Panchagnula R. Transdermal delivery of zidovudine: effect of terpenes and their mechanism of action. J Control Rel 2004, 95:367-379.
25. Panchagnula R., Salve P.S., Thomas N.S., Jain A.K., Ramarao P. Transdermal delivery of naloxone: effect of water, propylene glycol, ethanol and their binary combinations on permeation through rat skin. Int J Pharm 2001, 219:95-105.
26. Shakeel F., Baboota S., Ahuja A., Ali J., Shafiq S. Skin permeation mechanism and bioavailability enhancement of celecoxib from transdermally applied nanoemulsion. J Nanobiotechnology 2008, 6:8.
27. Dayan N., Touitou E. Carriers for skin delivery of trihexyphenidyl HCl: ethosomes vs. liposomes. Biomaterials 2000, 21:1879-1885.
28. Touitou E., Dayan N., Bergelson L., Godin B., Eliaz M. Ethosomes-novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J Control Rel 2000, 65:403-418.
29. Aqil M., Ali A., Sultana Y., Parvez N. Matrix type transdermal drug delivery systems of metoprolol tartrate: skin toxicity and in vivo characterization. Ethiop Pharm J 2004, 22:27-35.
30. Ghosh M.N. Fundamentals of experimental pharmacology 2005, Hilton and Company, Kolkata. 3rd ed.
31. Lopes L.B., Scarpa M.V., Silva G.V.J., Rodrigues D.C., Santilli C.V., Oliveira A.G. Studies on the encapsulation of Diclofenac in small unilamellar liposomes of soya phosphatidylcholine. Colloids Surf B: Biointerfaces 2004, 39:151-158.
32. Ning M.Y., Guo Y.Z., Pan H.Z., Yu H.M., Gu Z.W. Preparation and evaluation of proliposomes containing clotrimazole. Chem Pharm Bull (Tokyo) 2005, 53:620-624.
33. Van den Bergh B.A., Wertz P.W., Junginger H.E., Bouwstra J.A. Elasticity of vesicles assessed by electron spin resonance, electron microscopy and extrusion measurements. Int J Pharm 2001, 217:13-24.
34. Sultana S., Bhavna, Iqbal Z., Panda B.P., Talegaonkar S., Bhatnagar A., et al. Lacidipine encapsulated gastroretentive microspheres prepared by chemical denaturation for Pylorospasm. J Microencapsul 2009, 26:385-393.
35. Gannu R., Palem C.R., Yamsani S.K., Yamsani V.V., Yamsani M.R. Enhanced bioavailability of buspirone from reservoir-based transdermal therapeutic system, optimization of formulation employing Box-Behnken statistical design. AAPS PharmSciTech 2010, 11:976-985.
36. Lasch J., Hoffman J., Amelyaneenka W.G., Klibanov A.A., Torchilin V.P., Binder H., et al. Interaction of Triton X-100 and Octyl glycoside with liposomal membranes at sublytic and lytic concentration: spectroscopic studies. Biochim Biophys Acta 1990, 1022:171-180.
37. Lopez C., Maza A., Coderch L., Lpez Iglesias L., Wehli E., Parra J.L. Direct formation of mixed micelles in the solubilization of phospholipids liposome by Triton X-100. FEBS Lett 1998, 426:314-318.
38. Cevc G. Lipid vesicles and other colloids as drug carriers on the skin. Adv Drug Del Rev 2004, 56:675-711.
39. Jain S.K., Gupta Y., Jain A., Rai K. Enhanced transdermal delivery of acyclovir sodium via elastic liposomes. Drug Deliv 2008, 15:141-147.
40. Cevc G., Gebauer D., Schatzlein A., Blume G. Ultraflexible vesicles transfersomes have an extremely therapeutic amount of insulin across the intact mammalian skin. Biochim Biophys Acta 1998, 1368:201-215.
41. Cevc G., Schatzlein A., Blume G. Transdermal drug carrier basic properties, optimization and transfer efficiency in the case of epicutaneously applied peptides. J Control Rel 1995, 36:3-16.
42. Cevc G., Blume G., Schatzlein A. Transfersomes mediated transepidermal delivery improves the regiospecificity and biological activity of corticosteriods in vivo. J Control Rel 1997, 45:211-226.
43. El Maghraby G.M.M., Williams A.C., Barry B.W. Oestradiol skin delivery from ultradeformable liposomes, refinement of surfactant concentration. Int J Pharm 2000, 196:63-74.
44. Hiruta Y., Hattori Y., Kawano K., Obata Y., Maitani Y. Novel ultradeformable vesicles entrapped with bleomycin and enhanced to penetrate rat skin. J Control Rel 2006, 113:146-154.
45. Cevc G., Blume G., Schatzlein A., Gebauer D., Paul A. The skin: a pathway for the systemic treatment with patches and lipid based agent carrier. Adv Drug Deliv Rev 1996, 18:349-378.
46. El Maghraby G.M.M., Williams A.C., Barry B.W. Skin delivery of oestradiol from lipid vesicles: importance of liposome structure. Int J Pharm 2000, 204:159-169.
47. Chopra S., Patil G.V., Motwani S.K. Release modulating hydrophilic matrix systems of losartan potassium: optimisation of formulation using statistical experimental design. Eur J Pharm Biopharm 2007, 66:73-82.
48. Godin B., Touitou E. Mechanism of bacitracin permeation enhancement through the skin and cellular membranes from an ethosomal carrier. J Control Rel 2004, 94:365-379.
49. Dubey V., Mishra D., Jain N.K. Melatonin loaded ethanolic liposomes: physicochemical characterization and enhanced transdermal delivery. Eur J Pharm Biopharm 2007, 67:398-405.